FDA study approval nudges ANS (Advanced Neuromodulation Systems) closer to DBS (deep brain stimulation) market
This article was originally published in Clinica
Executive Summary
Advanced Neuromodulation Systems has stepped closer to moving into the deep brain stimulation (DBS) arena, after gaining permission from the US FDA to test its Libra DBS system in patients suffering from essential tremor.